Development Path
2021年
The Guiyang anti-tumor industry base was completed and put into use. A joint venture with Yangzhou Sanyao to establish a Jiangsu Furun API production base controlled by Fukangren
2020年
Complete A round of financing
Established Jinan Zhitong Clinical R&D Center
2018年
Joint venture with Shandong Ruiying to build an API production base
2017年
Established Jinan R&D Center
Established a joint venture with Shandong Fengjin Biopharmaceuticals to establish a raw material medicine industrial base in Yantai
2016年
Established Guiyang R&D Center
2014年
Paroxetine double-layer controlled-release tablet preparation technology transfer to EU
2011年
Acquired Foshan Yibaosheng Pharmaceutical Co., Ltd. and established a pilot plant for oral solids
2004年
Established a pilot base for APIs in Liaoyuan Yinying Pharmaceutical Co., Ltd.
2003年
The first batch to pass the “national high-tech enterprise” certification
The first batch to pass the “national high-tech enterprise” certification
1999年
Fukangren company was established
